Smith & Nephew SNATS, Inc. (NYSE:SNN) Shares Sold by Heartland Advisors Inc.

Key Points

• Heartland Advisors Inc. has reduced its stake in Smith & Nephew SNATS, Inc. by 17.7%, selling 77,135 shares to end the quarter with 359,854 shares valued at approximately $10.2 million.
• Institutional investors collectively own 25.64% of Smith & Nephew's stock, with several entities increasing their holdings significantly, including Bessemer Group Inc. which raised its stake by 3,471.4%.
• Recent analyst ratings show a shift as HSBC downgraded the stock from "buy" to "hold", while Canaccord Genuity increased its price objective, reflecting a generally cautious sentiment with a consensus rating of "Hold".

Heartland Advisors Inc. cut its stake in shares of Smith & Nephew SNATS, Inc. (NYSE:SNN - Free Report) by 17.7% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 359,854 shares of the medical equipment provider's stock after selling 77,135 shares during the period. Heartland Advisors Inc. owned 0.08% of Smith & Nephew SNATS worth $10,209,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in SNN. Bessemer Group Inc. boosted its position in Smith & Nephew SNATS by 3,471.4% during the 1st quarter. Bessemer Group Inc. now owns 1,750 shares of the medical equipment provider's stock valued at $49,000 after acquiring an additional 1,701 shares in the last quarter. Sei Investments Co. boosted its position in Smith & Nephew SNATS by 229.8% during the 4th quarter. Sei Investments Co. now owns 75,215 shares of the medical equipment provider's stock valued at $1,849,000 after acquiring an additional 52,411 shares in the last quarter. Sequoia Financial Advisors LLC bought a new stake in Smith & Nephew SNATS during the 1st quarter valued at $211,000. GAMMA Investing LLC boosted its position in Smith & Nephew SNATS by 22.4% during the 1st quarter. GAMMA Investing LLC now owns 3,641 shares of the medical equipment provider's stock valued at $103,000 after acquiring an additional 666 shares in the last quarter. Finally, Townsquare Capital LLC boosted its position in Smith & Nephew SNATS by 19.0% during the 4th quarter. Townsquare Capital LLC now owns 17,557 shares of the medical equipment provider's stock valued at $432,000 after acquiring an additional 2,798 shares in the last quarter. 25.64% of the stock is currently owned by hedge funds and other institutional investors.

Smith & Nephew SNATS Stock Down 1.5%

Shares of SNN stock traded down $0.48 on Monday, reaching $31.19. 531,041 shares of the stock were exchanged, compared to its average volume of 875,146. The company has a current ratio of 2.89, a quick ratio of 1.33 and a debt-to-equity ratio of 0.62. Smith & Nephew SNATS, Inc. has a twelve month low of $23.69 and a twelve month high of $31.84. The company has a market capitalization of $13.66 billion, a price-to-earnings ratio of 14.44, a PEG ratio of 0.97 and a beta of 0.69. The business's 50 day moving average price is $29.75 and its 200 day moving average price is $27.92.

Wall Street Analysts Forecast Growth

SNN has been the subject of several analyst reports. HSBC lowered Smith & Nephew SNATS from a "buy" rating to a "hold" rating in a report on Friday, April 25th. Canaccord Genuity Group increased their price objective on Smith & Nephew SNATS from $27.00 to $28.00 and gave the company a "hold" rating in a report on Thursday, May 1st. Finally, Hsbc Global Res cut Smith & Nephew SNATS from a "strong-buy" rating to a "hold" rating in a research report on Friday, April 25th. Six equities research analysts have rated the stock with a hold rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average price target of $28.00.

Smith & Nephew SNATS Company Profile

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT.